Bone and Soft Tissue Sarcomas (With Comments on Retroperitoneum)

  • Oisin HoughtonEmail author


Bone and Soft Tissue Sarcomas (with comments on Retroperitoneum): this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common sarcomas given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-sarcoma malignancies that are encountered at this site in diagnostic practice.


Bone sarcoma Soft tissue sarcoma TNM8 Liposarcoma Retroperitoneal tumours Immunochemistry 


  1. Al-Nafussi A. Practical morphological approach to the diagnosis and differential diagnosis of soft tissue sarcomas. Curr Diagn Pathol. 2002;8:395–411.CrossRefGoogle Scholar
  2. Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology. 2006;48:13–21.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Athanasou NA. Colour atlas of bone, joint and soft tissue pathology. Oxford: Oxford University Press; 1999.Google Scholar
  4. Brenn T, Fletcher CDM. Postradiation vascular proliferations: an increasing problem. Histopathology. 2006;48:106–14.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bullough PG. Orthopaedic pathology. 5th ed. St Louis: Mosby; 2010.Google Scholar
  6. Coffin CM, Lowichik A, Zhou H. Treatment effects in paediatric soft tissue and bone tumors. Am J Clin Pathol. 2005;123:75–90.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984;53:530–41.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Coindre J-M, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, de Mascarel I, de Mascarel A, Goussot JF. Reproducibility of a histopathogic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–9.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2003;43:1–16.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Dei Tos AP. Classification of pleomorphic sarcomas: where are we now? Histopathology. 2006;48:51–62.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology. 2006;48:42–50.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby Wolfe; 1998.Google Scholar
  13. Fechner RE, Mills SE. Tumors of the bones and joints, vol. 3. Washington DC: AFIP; 1993.Google Scholar
  14. Fisher C. The comparative roles of electron microscopy and immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2006;48:32–41.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Fisher C. Immunohistochemistry in diagnosis of soft tissue tumours. Histopathology. 2011;58:1001–12.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Fisher C, Montgomery E. Biopsy interpretation of soft tissue tumours. Philadelphia: Lippincott, Williams & Wilkins; 2010.Google Scholar
  17. Fletcher CDM. The evolving classification of soft tissue tumour: an update based on the new WHO classification. Histopathology. 2006;48:3–12.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO classification of tumours of soft tissue and bone. Lyon: IARC; 2012.Google Scholar
  19. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428–37.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Guillou L. Pleomorphic sarcomas: subclassification, myogenic differentiation and prognosis. Diagn Histopathol. 2008;14:527–37.CrossRefGoogle Scholar
  21. Hahn HP, Fletcher CDM. The role of cytogenetics and molecular genetics in soft tissue tumour diagnosis—a realistic approach. Curr Diagn Pathol. 2005;11:361–70.CrossRefGoogle Scholar
  22. Holloway P, Kay E, Leader M. Myxoid tumours: a guide to the morphological and immunohistochemical assessment of soft tissue myxoid lesions encountered in general surgical pathology. Curr Diagn Pathol. 2005;11:411–25.CrossRefGoogle Scholar
  23. Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology. 2006;48:75–82.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Tumors of the soft tissues, vol. 3. Washington, DC: AFIP; 2001.Google Scholar
  25. McCarthy EF, Frassica FJ. Pathology of bone and joint disorders. Philadelphia: Saunders; 1998.Google Scholar
  26. Miettinen MM. Diagnostic soft tissue pathology. London: Churchill Livingstone; 2003.Google Scholar
  27. Miettinen M, Fetsch JF. Evaluation of biological potential of smooth muscle tumours. Histopathology. 2006;48:97–105.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Mirra JM, Picci P, Gold RH. Bone tumours: clinical, radiological and pathological correlations. Baltimore: Lea and Febiger; 1989.Google Scholar
  29. Nascimento AF. Rhabdomyosarcomas in adults: classification and differential diagnosis. Diagn Histopathol. 2008;14:538–45.CrossRefGoogle Scholar
  30. Pfeifer JD, Hill DA, O’Sullivan MJ, Dehner LP. Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology. 2000;37:485–500.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Pringle JAS. Osteosarcoma: the experiences of a specialist unit. Curr Diagn Pathol. 1996;3:127–36.CrossRefGoogle Scholar
  32. Rossi S, Laurino L, Dei Tos AP. Desmoid-type fibromatosis: from morphology to molecular genetics. Diagn Histopathol. 2008;14:546–51.CrossRefGoogle Scholar
  33. Rossi S, Nascimento AG, Canal F, Dei Tos AP. Small round-cell neoplasms of soft tissues: an integrated diagnostic approach. Curr Diagn Pathol. 2007;13:150–63.CrossRefGoogle Scholar
  34. Sinha H, Peach AHS. Diagnosis and management of soft tissue sarcoma. BMJ. 2011a;342:157–62.Google Scholar
  35. The Royal College of Pathologists. Cancer datasets (primary bone tumours, soft tissue sarcomas) and tissue pathways (bone and soft tissue pathology). 2015.
  36. Unni KK, Inwards CY. Dahlin’s bone tumors. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2010.Google Scholar
  37. Unni KK, Inwards CY, Bridge JA, Kindblom LG, Wold LE. Tumors of the bones and joints. AFIP Atlas of tumor pathology, vol. 4. Washington, DC: AFIP; 2004.Google Scholar
  38. Weiss SW, Goldblum SR. Enzinger and Weiss’s soft tissue tumors. 5th ed. St Louis: Mosby; 2007.Google Scholar
  39. West RB, van de Rijn M. The role of microarray technologies in the study of soft tissue tumours. Histopathology. 2006;48:22–31.CrossRefPubMedPubMedCentralGoogle Scholar


  1. Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, et al. Short-course adjuvant chemotherapy in high-risk stage I non-seminomatous germ cell tumors of the testis: a medical research council report. J Clin Oncol. 1996;14:1106–13.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Parkinson MC, Harland SJ, Harnden P, Sandison A. The role of the histopathologist in the management of testicular germ cell tumour in adults. Histopathology. 2001;38:183–94.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Rosai J. Chapter 26. Peritoneum, retroperitoneum and related structures. In: Rosai J, editor. Rosai and Ackerman’s surgical pathology. 10th ed. Amsterdam: Elsevier; 2011.Google Scholar
  4. Sinha S, Peach AHS. Diagnosis and management of soft tissue sarcoma. BMJ. 2011b;342:157–62.Google Scholar
  5. Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, et al. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical research council testicular tumour working party. Cancer. 1998;83:1409–19.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of PathologyRoyal Victoria HospitalBelfastUK

Personalised recommendations